Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma

Guocai Tian(L-3 Communications (United States)), Xi Yang(Shanghai Jiao Tong University), Dahe Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiang Li(Affiliated Hospital of North Sichuan Medical College), Zhiyuan Zhang(Shanghai Medical College of Fudan University), You Fu(Jinan University)
Cancer Cell International
March 12, 2021
10.1186/s12935-021-01863-6
Cited by 10

Related Papers

Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies
|Cell Metabolism|2022|135
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations
|Clinical Cancer Research|2019|131
T-Cell Mineralocorticoid Receptor Controls Blood Pressure by Regulating Interferon-Gamma
|Circulation Research|2017|129
The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma
|Molecular Cancer|2022|123
Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma
|Cancer Letters|2021|120